NEULASTIM Side Effects

6779854-X | Anaphylactic Shock
on Jun 10, 2010 Male patient from ISRAEL , 37 years of age, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Neulastim dosage: . During the same period patient was treated with PRAMIN (View Pramin Review and Pramin Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6581163-9 | Pericardial Effusion, Pleural Effusion
Patient was taking Neulastim (View Usage). Patient had the following side effects: pericardial effusion, pleural effusion on Feb 08, 2010 from MEXICO Additional patient health information: Female patient , weighting 208.3 lb, . Neulastim dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6491635-3 | Neutropenia, Sepsis
Adverse event was reported on Dec 01, 2009 by a Female patient taking Neulastim (View Usage) (Dosage: ) . Location: JORDAN , 63 years of age, After Neulastim was administered, patient had the following side effects: neutropenia, sepsis (What is sepsis?). During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6476177-3 | Leukocytosis, Thrombocytopenia, Thrombocytosis
on Nov 25, 2009 Female patient from ISRAEL , 86 years of age, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytosis, thrombocytopenia, thrombocytosis. Neulastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).


6244513-9 | Dyspnoea, Headache, Hypotension, Vomiting
on Jun 16, 2009 Female patient from MEXICO , child 6 years of age, was diagnosed with neutropenia and was treated with Neulastim (View Usage). Patient had the following side effects: dyspnoea, headache (What is headache?), hypotension, vomiting. Neulastim dosage: .

6184885-7 | Pericardial Effusion, Pleural Effusion
Patient was taking Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: pericardial effusion, pleural effusion on Apr 23, 2009 from MEXICO Additional patient health information: Female patient , weighting 208.3 lb, . Neulastim dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6184533-6 | Anaemia, Neutropenia, Thrombocytopenia
Adverse event was reported on Apr 28, 2009 by a Female patient taking Neulastim (View Usage) (Dosage: ) . Location: UNITED ARAB EMIRATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, neutropenia, thrombocytopenia. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), FEMARA (View Femara Review and Femara Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6125962-6 | Arthralgia, Asthenia, Myalgia, Pyrexia
on Mar 09, 2009 Female patient from MEXICO , 72 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Neulastim (View Usage). Patient had the following side effects: arthralgia, asthenia, myalgia, pyrexia. Neulastim dosage: .

6124006-X | Arthralgia, Asthenia, Myalgia, Pyrexia
on Mar 09, 2009 Female patient from MEXICO , 28 years of age, was treated with Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: arthralgia, asthenia, myalgia, pyrexia. Neulastim dosage: .

6115467-0 | Neutrophil Count Decreased
Patient was taking Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased on Mar 05, 2009 from INDIA Additional patient health information: Female patient , 54 years of age, weighting 132.3 lb, was diagnosed with neutropenia, non-hodgkin's lymphoma and. Neulastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6085390-9 | Febrile Neutropenia
Adverse event was reported on Feb 11, 2009 by a Female patient taking Neulastim (View Usage) (Dosage: ) . Location: UNITED ARAB EMIRATES , weighting 147.7 lb, Patient had the following side effects: febrile neutropenia. During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ).

6083638-8 | Febrile Neutropenia
on Feb 09, 2009 Male patient from UNITED ARAB EMIRATES , weighting 170.9 lb, was diagnosed with neutropenia and was treated with Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: febrile neutropenia. Neulastim dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6083637-6 | Febrile Neutropenia
on Feb 10, 2009 Female patient from UNITED ARAB EMIRATES , weighting 148.4 lb, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Neulastim dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6068375-8 | Pneumonitis
Patient was taking Neulastim (View Usage). Patient had the following side effects: pneumonitis on Jan 29, 2009 from ISRAEL Additional patient health information: Female patient , 80 years of age, . Neulastim dosage: . During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), VINBLASTINE (View Vinblastine Review and Vinblastine Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ). Patient was hospitalized.

5968917-4 | Disease Progression, Leukocytosis, Shift To The Left
Adverse event was reported on Nov 18, 2008 by a Female patient taking Neulastim (View Usage) (Dosage: ) . Location: ISRAEL , 26 years of age, After Neulastim was administered, patient had the following side effects: disease progression, leukocytosis, shift to the left. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5825557-5 | Cyanosis, Dyspnoea, Musculoskeletal Pain
on Jul 18, 2008 Male patient from COLOMBIA , 21 years of age, weighting 121.3 lb, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, dyspnoea, musculoskeletal pain. Neulastim dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), MESNA (View Mesna Review and Mesna Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5793016-4 | Neutropenia
on Jun 17, 2008 Male patient from HONG KONG , 60 years of age, was treated with Neulastim (View Usage). Patient had the following side effects: neutropenia. Neulastim dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5766871-1 | Febrile Neutropenia
Patient was taking Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: febrile neutropenia on Jun 03, 2008 from THAILAND Additional patient health information: Female patient , 59 years of age, . Neulastim dosage: . Patient was hospitalized.

5747003-2 | Diarrhoea Infectious, Gastroenteritis, Neutropenia
Adverse event was reported on May 15, 2008 by a Female patient taking Neulastim (View Usage) (Dosage: ) . Location: UNITED ARAB EMIRATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea infectious, gastroenteritis (What is gastroenteritis?), neutropenia. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5746391-0 | Diarrhoea, Neutropenia
on May 15, 2008 Female patient from UNITED ARAB EMIRATES , 60 years of age, was treated with Neulastim (View Usage). Patient had the following side effects: diarrhoea, neutropenia. Neulastim dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ). Patient was hospitalized.

5739246-9 | Anaphylactic Reaction, Cardiac Arrest, Hepatic Failure, Renal Failure
on May 07, 2008 Male patient from THAILAND , 59 years of age, was treated with Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: anaphylactic reaction, cardiac arrest (What is cardiac arrest?), hepatic failure, renal failure. Neulastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5678561-4 | Adverse Event, Confusional State, Convulsion, Dizziness, Leukocytosis, Nausea, Syncope
Patient was taking Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, confusional state, convulsion, dizziness (What is dizziness?), leukocytosis, nausea (What is nausea?), syncope on Mar 11, 2008 from ISRAEL Additional patient health information: Male patient , 50 years of age, . Neulastim dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

5672266-1 | Anaphylactic Reaction, Blood Pressure Decreased
Adverse event was reported on Mar 05, 2008 by a Male patient taking Neulastim (View Usage) (Dosage: ) . Location: THAILAND , 37 years of age, Patient had the following side effects: anaphylactic reaction, blood pressure decreased. During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

5661581-3 | Febrile Neutropenia
on Feb 27, 2008 Female patient from MALAYSIA , weighting 129.0 lb, was treated with Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: febrile neutropenia. Neulastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5661554-0 | Febrile Neutropenia
on Feb 27, 2008 Male patient from MALAYSIA , weighting 139.6 lb, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Neulastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5644385-7 | Back Pain
Patient was taking Neulastim (View Usage). Patient had the following side effects: back pain (What is back pain?) on Feb 18, 2008 from INDONESIA Additional patient health information: Female patient , 60 years of age, . Neulastim dosage: .

5640604-1 | Febrile Neutropenia, No Therapeutic Response
Adverse event was reported on Feb 14, 2008 by a Male patient taking Neulastim (View Usage) (Dosage: ) . Location: INDIA , 47 years of age, After Neulastim was administered, patient had the following side effects: febrile neutropenia, no therapeutic response. During the same period patient was treated with DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

5626140-7 | Bone Marrow Disorder, Bone Pain, Leukocytosis, Osteonecrosis
on Feb 01, 2008 Male patient from ISRAEL , 30 years of age, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow disorder, bone pain, leukocytosis, osteonecrosis (What is osteonecrosis?). Neulastim dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

5613758-0 | Febrile Neutropenia
on Jan 22, 2008 Female patient from INDIA , 42 years of age, weighting 172.0 lb, was treated with Neulastim (View Usage). Patient had the following side effects: febrile neutropenia. Neulastim dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

5569525-X | Full Blood Count Decreased, Septic Shock
Patient was taking Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: full blood count decreased, septic shock on Dec 12, 2007 from INDIA Additional patient health information: Female patient , 62 years of age, . Neulastim dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5562770-9 | Joint Hyperextension, Neck Pain
Adverse event was reported on Dec 03, 2007 by a Female patient taking Neulastim (View Usage) (Dosage: ) . Location: BRAZIL , 35 years of age, weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: joint hyperextension, neck pain. During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5550141-0 | Adverse Event, Convulsion, Dizziness, Leukocytosis, Nausea, Syncope
on Nov 29, 2007 Male patient from ISRAEL , 50 years of age, was treated with Neulastim (View Usage). Patient had the following side effects: adverse event, convulsion, dizziness (What is dizziness?), leukocytosis, nausea (What is nausea?), syncope. Neulastim dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

5514013-X | Joint Hyperextension, Neck Pain
on Nov 01, 2007 Female patient from BRAZIL , 35 years of age, weighting 187.4 lb, was treated with Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: joint hyperextension, neck pain. Neulastim dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5514005-0 | Febrile Neutropenia, Respiratory Failure, Septic Shock
Patient was taking Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, respiratory failure, septic shock on Oct 30, 2007 from ISRAEL Additional patient health information: Female patient , 45 years of age, weighting 110.2 lb, . Neulastim dosage: . During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

5503391-3 | Dysphagia, Dyspnoea, Erythema, Eye Pruritus, Ocular Hyperaemia
Adverse event was reported on Oct 12, 2007 by a Male patient taking Neulastim (View Usage) (Dosage: ) . Location: ISRAEL , 50 years of age, weighting 165.3 lb, Patient had the following side effects: dysphagia, dyspnoea, erythema, eye pruritus, ocular hyperaemia. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

5471312-8 | Asthenia, Back Pain, Cold Sweat, Hypotension
on Sep 13, 2007 Male patient from MEXICO , 49 years of age, weighting 194.0 lb, was treated with Neulastim (View Usage). After Neulastim was administered, patient had the following side effects: asthenia, back pain (What is back pain?), cold sweat, hypotension. Neulastim dosage: . During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

5444234-6 | Dysphagia, Dyspnoea, Erythema, Eye Pruritus, Ocular Hyperaemia
on Aug 23, 2007 Male patient from ISRAEL , 50 years of age, weighting 165.3 lb, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, dyspnoea, erythema, eye pruritus, ocular hyperaemia. Neulastim dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

5425989-3 | Cardiopulmonary Failure, Dyspnoea
Patient was taking Neulastim (View Usage). Patient had the following side effects: cardiopulmonary failure, dyspnoea on Aug 15, 2007 from ISRAEL Additional patient health information: Male patient , 75 years of age, . Neulastim dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DEXRAZOXANE (View Dexrazoxane Review and Dexrazoxane Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

5323767-7 | Septic Shock
Adverse event was reported on May 01, 2007 by a Male patient taking Neulastim (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: , 60 years of age, After Neulastim was administered, patient had the following side effects: septic shock. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

5158583-2 | Febrile Neutropenia
on Nov 16, 2006 Female patient from ISRAEL , 40 years of age, was treated with Neulastim (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Neulastim dosage: . Patient was hospitalized.

5158579-0 | Febrile Neutropenia
on Nov 16, 2006 Male patient from ISRAEL , 73 years of age, was treated with Neulastim (View Usage). Patient had the following side effects: febrile neutropenia. Neulastim dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.